Section of Plastic Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.
Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
PM R. 2023 Nov;15(11):1457-1465. doi: 10.1002/pmrj.12972. Epub 2023 May 28.
Nerve pain frequently develops following amputations and peripheral nerve injuries. Two innovative surgical techniques, targeted muscle reinnervation (TMR) and regenerative peripheral nerve interfaces (RPNI), are rapidly gaining popularity as alternatives to traditional nerve management, but their effectiveness is unclear.
A review of literature pertaining to TMR and RPNI pain results was conducted. PubMed and MEDLINE electronic databases were queried.
Studies were included if pain outcomes were assessed after TMR or RPNI in the upper or lower extremity, both for prophylaxis performed at the time of amputation and for treatment of postamputation pain. Data were extracted for evaluation.
Seventeen studies were included, with 14 evaluating TMR (366 patients) and three evaluating RPNI (75 patients). Of these, one study was a randomized controlled trial. Nine studies had a mean follow-up time of at least 1 year (range 4-27.6 months). For pain treatment, TMR and RPNI improved neuroma pain in 75%-100% of patients and phantom limb pain in 45%-80% of patients, averaging a 2.4-6.2-point reduction in pain scores on the numeric rating scale postoperatively. When TMR or RPNI was performed prophylactically, many patients reported no neuroma pain (48%-100%) or phantom limb pain (45%-87%) at time of follow-up. Six TMR studies reported Patient-Reported Outcomes Measurement Information System (PROMIS) scores assessing pain intensity, behavior, and interference, which consistently showed a benefit for all measures. Complication rates ranged from 13% to 31%, most frequently delayed wound healing.
Both TMR and RPNI may be beneficial for preventing and treating pain originating from peripheral nerve dysfunction compared to traditional techniques. Randomized trials with longer term follow-up are needed to directly compare the effectiveness of TMR and RPNI with traditional nerve management techniques.
神经痛常发生于截肢和周围神经损伤后。两种创新的外科技术,靶向肌肉神经再支配(TMR)和再生周围神经接口(RPNI),正在迅速成为传统神经管理的替代方法,但它们的效果尚不清楚。
对 TMR 和 RPNI 疼痛结果的文献进行了综述。检索了 PubMed 和 MEDLINE 电子数据库。
如果在上下肢中评估了 TMR 或 RPNI 后的疼痛结果,并且是在截肢时进行预防还是治疗截肢后疼痛,那么研究就包括在内。提取数据进行评估。
共纳入 17 项研究,其中 14 项评估 TMR(366 例患者),3 项评估 RPNI(75 例患者)。其中一项研究为随机对照试验。9 项研究的平均随访时间至少为 1 年(范围 4-27.6 个月)。对于疼痛治疗,TMR 和 RPNI 可改善 75%-100%的患者的神经瘤疼痛和 45%-80%的患者的幻肢痛,术后数字评分法疼痛评分平均降低 2.4-6.2 分。当预防性地进行 TMR 或 RPNI 时,许多患者在随访时报告没有神经瘤疼痛(48%-100%)或幻肢痛(45%-87%)。6 项 TMR 研究报告了患者报告的结局测量信息系统(PROMIS)评分,评估疼痛强度、行为和干扰,所有测量均显示出获益。并发症发生率从 13%到 31%不等,最常见的是延迟伤口愈合。
与传统技术相比,TMR 和 RPNI 可能有助于预防和治疗外周神经功能障碍引起的疼痛。需要进行长期随访的随机试验来直接比较 TMR 和 RPNI 与传统神经管理技术的效果。